Table 1.

Table 1A: α, β, α/β, OER (oxygen enhancement ratio) and VER (virus enhancement ratio) for HCT8 cells infected with recombinant adenovirus containing DNKu70 fragment.
HCT8 Cells	α ± SE	β ± SE	α/β ± SE	VER at SF of			OER at SF of
				0.5	0.1	0.01	0.5	0.1	0.01
Cont. (O)-0h	−0.216 ± 0.078	−0.0637 ± 0.0092	3.39 ± 1.33
Cont. (O)-6h	−0.142 ± 0.059	−0.0508 ± 0.0069	2.79 ± 1.22
Virus (O)-0h	−0.458 ± 0.067	−0.0594 ± 0.0107	7.71 ± 1.80	1.55	1.31	1.21
Virus (O)-6h	−0.333 ± 0.068	−0.0486 ± 0.0107	6.86 ± 2.06	1.53	1.29	1.19
Cont. (H)-0h	−0.104 ± 0.012	−0.00572 ± 0.00047	18.23 ± 2.58				2.57	2.84	2.97
Cont. (H)-6h	−0.161 ± 0.017	−0.00372 ± 0.00065	43.33 ± 8.77				1.55	2.07	2.39
Virus (H)-0h	−0.207 ± 0.003	−0.00449 ± 0.00016	46.15 ± 1.76	1.65	1.40	1.26	2.42	2.67	2.85
Virus (H)-6h	−0.222 ± 0.036	−0.00310 ± 0.00189	71.72 ± 45.26	1.32	1.23	1.17	1.79	2.15	2.44

Table 1B: α, β, α/β, OER (oxygen enhancement ratio) and VER (virus enhancement ratio) for HT29 cells infected with recombinant adenovirus containing DNKu70 fragment.
HT29 Cells	α ± SE	β ± SE	α/β ± SE	VER at SF of			OER at SF of
				0.5	0.1	0.01	0.5	0.1	0.01
Cont. (O)-0h	−0.125 ± 0.068	−0.0391 ± 0.0067	3.19 ± 1.82
Cont. (O)-6h	−0.067 ± 0.033	−0.0356 ± 0.0033	1.89 ± 0.95
Virus (O)-0h	−0.385 ± 0.069	−0.0387 ± 0.0081	9.95 ± 2.74	1.87	1.48	1.34
Virus (O)-6h	−0.302 ± 0.046	−0.0275 ± 0.0054	10.99 ± 2.73	1.83	1.38	1.22
Cont. (H)-0h	−0.139 ± 0.005	−0.00186 ± 0.00015	75.09 ± 6.62				1.61	2.23	2.65
Cont. (H)-6h	−0.158 ± 0.025	−0.00119 ± 0.00114	133.31 ± 111.1				1.19	1.85	2.35
Virus (H)-0h	−0.139 ± 0.014	−0.00384 ± 0.00064	36.22 ± 7.05	1.06	1.13	1.19	2.85	2.93	2.99
Virus (H)-6h	−0.142 ± 0.025	−0.00418 ± 0.00115	33.86 ± 9.30	0.98	1.10	1.21	2.23	2.32	2.37